menu
    • menu

    Company profile for Syndax Pharmaceuticals

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We are a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Entinostat was granted Breakthrough Therapy designation by the U.S. Food and Drug Administration following positive results from our Phase 2b clinical trial, ENCORE 301, and is currently being evaluated in a...
    At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We are a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Entinostat was granted Breakthrough Therapy designation by the U.S. Food and Drug Administration following positive results from our Phase 2b clinical trial, ENCORE 301, and is currently being evaluated in a Phase 3 clinical trial for advanced hormone receptor positive breast cancer in combination with exemestane, E2112.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Syndax PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    35 Gatehouse Drive Building D, Floor 3 Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://syndax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/syndax-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syndax Showcases 12 Revuforj Abstracts at EHA 2026
    Syndax Showcases 12 Revuforj Abstracts at EHA 2026

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293092/0/en/syndax-highlights-12-revuforj-revumenib-abstracts-accepted-for-eha-2026-advancing-leadership-in-menin-inhibition.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Syndax Unveils Q1 2026 Financials And Business Update
    Syndax Unveils Q1 2026 Financials And Business Update

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257110

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    Syndax To Unveil Q1 2026 Financial Results, Host Conference Call
    Syndax To Unveil Q1 2026 Financial Results, Host Conference Call

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3280693/0/en/syndax-to-announce-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-april-30-2026.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    Syndax Pharma Awards Inducement Grants Under Nasdaq Listing Rule
    Syndax Pharma Awards Inducement Grants Under Nasdaq Listing Rule

    03 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/03/3268134/0/en/Syndax-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Apr 2026
    Share Share
    Syndax Pharma Reports Inducement Grants per NASDAQ LR 5635(c)(4)
    Syndax Pharma Reports Inducement Grants per NASDAQ LR 5635(c)(4)

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249711/0/en/Syndax-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Syndax Announces Participation In March Investor Conferences
    Syndax Announces Participation In March Investor Conferences

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242464/0/en/Syndax-Announces-Participation-in-March-Investor-Conferences.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search